EP0300688A1 — Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
Assigned to Fisons Ltd · Expires 1989-01-25 · 37y expired
What this patent protects
Compounds of formula I, wherein R₁, R₂, R₃ and R₅ have the meanings defined in the specification, G2 represents a chain -(CH₂) z (W) y -, in which W has various meanings including C=O, and up to two of the methylene segments in the chain (CH₂) z are optionally replaced b…
USPTO Abstract
Compounds of formula I, wherein R₁, R₂, R₃ and R₅ have the meanings defined in the specification, G2 represents a chain -(CH₂) z (W) y -, in which W has various meanings including C=O, and up to two of the methylene segments in the chain (CH₂) z are optionally replaced by -NH- and one segment is optionally replaced by -O- or -(C=NR₄₀)-, and the chain is optionally unsaturated and optionally substituted, and A is a 5- or 6-membered ring or a bicyclic or tricyclic fused ring system, A being optionally substituted by various substituents, possess useful pharmacological properties, in particular as cardiotonics. Also described are processes for the preparation of compounds of formula I, pharmaceutical compositions containing them and methods of treatment involving their use.
Drugs covered by this patent
- Vumerity (DIROXIMEL FUMARATE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.